A structural perspective on nuclear receptors as targets of environmental compounds

被引:93
作者
Delfosse, Vanessa [1 ,2 ,3 ]
le Maire, Albane [1 ,2 ,3 ]
Balaguer, Patrick [4 ,5 ,6 ,7 ]
Bourguet, William [1 ,2 ,3 ]
机构
[1] INSERM, U1054, Montpellier, France
[2] Univ Montpellier I, CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France
[3] Univ Montpellier 2, CNRS, UMR5048, Ctr Biochim Struct, Montpellier, France
[4] IRCM, Montpellier, France
[5] INSERM, U896, Montpellier, France
[6] Univ Montpellier I, Montpellier, France
[7] Inst Reg Canc Montpellier, ICM, Montpellier, France
关键词
nuclear receptors; endocrine disruptor; environmental pollutant; transcription misregulation; crystal structure; PROLIFERATOR-ACTIVATED RECEPTORS; ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING DOMAIN; UNION-OF-PHARMACOLOGY; ESTROGEN-RECEPTOR; PPAR-GAMMA; ORGANOTIN COMPOUNDS; BISPHENOL-A; ER-ALPHA; ADIPOCYTE DIFFERENTIATION;
D O I
10.1038/aps.2014.133
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nuclear receptors (NRs) are members of a large superfamily of evolutionarily related transcription factors that control a plethora of biological processes. NRs orchestrate complex events such as development, organ homeostasis, metabolism, immune function, and reproduction. Approximately one-half of the 48 human NRs have been shown to act as ligand-regulated transcription factors and respond directly to a large variety of endogenous hormones and metabolites that are generally hydrophobic and small in size (eg, retinoic acid or estradiol). The second half of the NR family comprises the so-called orphan receptors, for which regulatory ligands are still unknown or may not exist despite the presence of a C-terminal ligand-binding domain, which is the hallmark of all NRs. Several chemicals released into the environment (eg, bisphenols, phthalates, parabens, etc) share some physicochemical properties with natural ligands, allowing them to bind to NRs and activate or inhibit their action. Collectively referred to as endocrine disruptors or endocrine-disrupting chemicals (EDCs), these environmental pollutants are highly suspected to cause a wide range of developmental, reproductive, neurological, or metabolic defects in humans and wildlife. Crystallographic studies are revealing unanticipated mechanisms by which chemically diverse EDCs interact with the ligand-binding domain of NRs. These studies thereby provide a rational basis for designing novel chemicals with lower impacts on human and animal health. In this review, we provide a structural and mechanistic view of endocrine disrupting action using estrogen receptors alpha and beta, (ER alpha/beta), peroxisome proliferator activated receptor gamma (PPAR gamma), and their respective environmental ligands as representative examples.
引用
收藏
页码:88 / 101
页数:14
相关论文
共 90 条
[1]   PPARγ signaling and metabolism: the good, the bad and the future [J].
Ahmadian, Maryam ;
Suh, Jae Myoung ;
Hah, Nasun ;
Liddle, Christopher ;
Atkins, Annette R. ;
Downes, Michael ;
Evans, Ronald M. .
NATURE MEDICINE, 2013, 19 (05) :557-566
[2]   Environmental levels, toxicity and human exposure to tributyltin (TBT)-contaminated marine environment. A review [J].
Antizar-Ladislao, Blanca .
ENVIRONMENT INTERNATIONAL, 2008, 34 (02) :292-308
[3]   Organotin compounds: Toxicokinetic aspects [J].
Appel, KE .
DRUG METABOLISM REVIEWS, 2004, 36 (3-4) :763-786
[4]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[5]   Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network [J].
Bookout, Angie L. ;
Jeong, Yangsik ;
Downes, Michael ;
Yu, Ruth T. ;
Evans, Ronald M. ;
Mangelsdorf, David J. .
CELL, 2006, 126 (04) :789-799
[6]   Exposure to an organochlorine pesticide (chlordecone) and development of 18-month-old infants [J].
Boucher, Olivier ;
Simard, Marie-Noelle ;
Muckle, Gina ;
Rouget, Florence ;
Kadhel, Philippe ;
Bataille, Henri ;
Chajes, Veronique ;
Dallaire, Renee ;
Monfort, Christine ;
Thome, Jean-Pierre ;
Multigner, Luc ;
Cordier, Sylvaine .
NEUROTOXICOLOGY, 2013, 35 :162-168
[7]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[8]  
Bourguet W, 2010, METHOD ENZYMOL, V485, P161, DOI [10.1016/S0076-6879(10)85010-4, 10.1016/B978-0-12-381296-4.00010-5]
[9]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[10]   Resveratrol and Its Metabolites Bind to PPARs [J].
Calleri, Enrica ;
Pochetti, Giorgio ;
Dossou, Katina S. S. ;
Laghezza, Antonio ;
Montanari, Roberta ;
Capelli, Davide ;
Prada, Ellen ;
Loiodice, Fulvio ;
Massolini, Gabriella ;
Bernier, Michel ;
Moaddel, Ruin .
CHEMBIOCHEM, 2014, 15 (08) :1154-1160